JENNIFER CRAYNER-ARYEE: Open Payments
NPI 1396166237 · VERONA, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,165 in 56 payments from 11 companies in 2025. Trend: 2023 $163 · 2024 $665 · 2025 $1,165
Food & beverage: $944Education: $221
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $315 |
| United Therapeutics Corporation | 10 | $169 |
| AstraZeneca Pharmaceuticals LP | 8 | $141 |
| Merck Sharp & Dohme LLC | 8 | $139 |
| GlaxoSmithKline, LLC. | 6 | $129 |
| Actelion Pharmaceuticals US, Inc. | 5 | $83 |
| Viatris Specialty LLC | 3 | $61 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $46 |
| Invivyd Inc | 1 | $18 |
Products named: WINREVAIR, TRELEGY ELLIPTA, Cresemba, Tyvaso, FASENRA, UPTRAVI, YUPELRI, TEZSPIRE.
Industry payments across NJ — which companies pay providers there.
